Malaysia: NPRA's Transition to Remote GDP Inspections (w.e.f. 18 December 2024)

France: Navigating Clinical Trial Compliance Before the January 2025 Deadline

Indonesia: Online Certification and Medical Device Licensing Systems to Close Temporarily

Australia: TGA Updates Labeling Requirements and Guidelines for Injectable Medicines

Philippines: Comprehensive Framework for FDA LTO Application of Covered Health Product Establishments

Singapore: HSA Launches Pilot for Change Management Program (CMP) Targeting SaMD and AI-Driven Innovations (w.e.f 4 December 2024)

China: NMPA Introduces Interim Provisions on Domestic Responsible Persons Designated by Overseas Drug Marketing Authorization Holders (w.e.f 1 July 2025)

United Kingdom: MHRA Urges MAHs to Finalize Windsor Framework Adjustment

Canada: Key Guidelines to Crafting an Effective CAPA Plan by Health Canada

Vietnam: Addressing Import License Expirations in Vietnam (by 25 December 2024)

Malaysia: NPRA Bans Chloroform and Chloroform Spirit as Preservatives (w.e.f. 19 November 2024)

Australia: Key Deadlines for Patient-Matched Medical Devices (PMDDs)